id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2013-0002-0008,DEA,DEA-2013-0002,Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV,Rule,,2014-02-27T05:00:00Z,2014,2,2014-02-27T05:00:00Z,,2014-02-27T14:53:19Z,2014-04332,0,0,09000064815d84db
DEA-2013-0002-0002,DEA,DEA-2013-0002,HHS Alfaxalone 8 Factor Analysis,Supporting & Related Material,,2013-03-25T04:00:00Z,2013,3,,,2013-03-25T20:34:26Z,,0,0,0900006481243a9c
DEA-2013-0002-0001,DEA,DEA-2013-0002,Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV,Proposed Rule,,2013-03-25T04:00:00Z,2013,3,2013-03-25T04:00:00Z,2013-04-25T03:59:59Z,2013-04-24T01:05:32Z,2013-06651,0,0,09000064812416e6
DEA-2013-0002-0003,DEA,DEA-2013-0002,Alfaxalone DEA 8 Factor Review,Supporting & Related Material,,2013-03-25T04:00:00Z,2013,3,,,2013-03-25T20:34:26Z,,0,0,0900006481243a9b